Moxifloxacin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Moxifloxacin and local guidelines before prescribing.

Fluoroquinolone antibiotic

Mechanism

Fluoroquinolone inhibiting DNA gyrase and topoisomerase IV.

Uses

Community-acquired pneumonia (second line), TB (second line), pelvic infection (specialist).

Dosing

Side effects

Tendinopathy, QT prolongation, C. difficile, aortic aneurysm, neuropsychiatric effects, hypoglycaemia.

Interactions

QT-prolonging drugs; corticosteroids increase tendon rupture risk; antacids reduce absorption.

Contraindications and cautions

Tendon disorder, QT prolongation, severe hepatic impairment

Monitoring

ECG, tendon pain

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Avoid in severe liver impairment

Overdose and reversal

Supportive

Special advice

Restricted to specialist guidance under MHRA warnings; stop at first tendon pain.

More from the textbook: uses, cautions and other points
Where it is discussed in the book